News Releases

Feb 17, 2022
Lyra Therapeutics Appoints Harlan W. Waksal, MD, as Executive Chairman
Recent President and Chief Executive Officer of Kadmon brings vast experience leading and scaling late-stage and commercial biopharmaceutical companies WATERTOWN, Mass. , Feb. 17, 2022 /PRNewswire/ -- Lyra Therapeutics today announced the appointment of Harlan W. Waksal MD, as Executive Chairman.
Additional Formats
Displaying 21 - 23 of 23
Print Page
Email Alerts
RSS Feeds
Contact IR
Search
Back to Top